Related Experiment Video

Updated: Nov 19, 2025

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.5K

In-Hospital Peak Glycemia in Predicting No-Reflow Phenomenon in Diabetic Patients with STEMI Treated with Primary

Fang Liu1, Rui Huang1, Ya Li1

  • 1Department 2 of Cardiology, Cangzhou Central Hospital, No. 16 Xinhua Road, Cangzhou, 061000 Hebei, China.

Journal of Diabetes Research
|January 28, 2021
PubMed

Insights

High blood sugar before percutaneous coronary intervention (PCI) increases the risk of the no-reflow phenomenon in diabetic patients with ST-segment elevation myocardial infarction (STEMI). Controlling glucose levels is crucial for better outcomes after PCI.

Area of Science:

  • Cardiology
  • Diabetology
  • Interventional Cardiology

Background:

  • Percutaneous coronary intervention (PCI) improves outcomes for myocardial infarction.
  • The no-reflow phenomenon is a significant complication of PCI, increasing mortality, particularly in diabetic patients with ST-segment elevation myocardial infarction (STEMI).
  • Identifying prognostic factors for no-reflow is essential for risk stratification and management before PCI.

Purpose of the Study:

  • To identify prognostic factors for the no-reflow phenomenon in diabetic patients undergoing primary PCI for STEMI.
  • To investigate the association between glycemic control and the occurrence of no-reflow post-PCI.

Main Methods:

  • A cohort of 262 diabetic patients with acute STEMI undergoing primary PCI was analyzed.
  • Patients were categorized into normal flow and no-reflow groups based on Thrombolysis in Myocardial Infarction (TIMI) flow.
  • Multivariate logistic regression analysis was employed to determine independent predictors of no-reflow.

Main Results:

  • The no-reflow group exhibited significantly higher in-hospital peak glycemia compared to the normal flow group.
  • Factors such as more narrowed vessels and higher initial TIMI flow were also observed more frequently in the no-reflow group.
  • Peak glycemia was identified as an independent predictor of no-reflow in diabetic STEMI patients.

Conclusions:

  • Elevated peak glycemia is a significant independent predictor of the no-reflow phenomenon in diabetic patients with STEMI undergoing PCI.
  • Optimal glucose control prior to PCI may be crucial in reducing the incidence of no-reflow and improving outcomes in this patient population.

More Related Videos

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.5K
Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

4.0K

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
288
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
96
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
92
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
546